Delivering on phase 1 and 2 production targets is the key strategic priority.
Phase 2 ramp-up and operation according to plan, with the third smolt release completed in July.
Farming EBITDA of -13.3 NOKm and Group EBITDA of -20.2 NOKm.
2027E harvest guidance of 11,000 to 12,000 tonnes HOG, 2026E harvest guidance updated to 5,500 tonnes HOG after using available flexibility to move phase 2 first harvest to Q1-27.
Additional funding is in place through a new credit facility of 200 NOKm and an increase in the overdraft facility from 200 to 300 NOKm.
Key figures
Operational
Q3 2026
Q3 2025
YTD 2026
YTD 2025
2025
Standing biomass (tonnes, LW)
2 936
3 009
2 936
3 009
3 115
Net growth (tonnes, LW)
1 984
1 797
5 048
5 025
6 451
Harvest volumes (tonnes, HOG)
1 597
1 387
4 306
3 201
4 403
All-in price realization/kg (NOK)1
64,3
61,1
73,6
67,8
69,5
Farming EBITDA/kg
-8,3
-22,1
0,3
-11,9
-9,0
Farming costs/kg (NOK)
71,3
81,8
71,7
80,3
77,1
Financial (in NOK thousand)
Q3 2026
Q3 2025
YTD 2026
YTD 2025
2025
Operating revenues
104 852
86 475
323 776
227 284
326 022
Operational EBITDA2
-20 200
-40 507
-21 891
-70 255
-78 686
Operational EBIT2
-41 045
-61 470
-83 584
-133 730
-158 906
Profit (loss) before tax
-25 683
-46 301
-107 311
-172 748
-171 601
Cash flow from operations
-1 502
-40 610
-50 010
-82 050
-59 052
Operational EBITDA Farming Norway2
-13 294
-30 592
1 309
-38 177
-39 483
Capital structure (in NOK thousand)
Q3 2026
Q3 2025
YTD 2026
YTD 2025
2025
Cash flow from investment activities
-199 028
-348 748
-728 341
-861 268
-1 252 431
Cash flow from financing activities
113 771
416 951
808 716
670 210
1 045 458
Cash and cash equivalents
193 802
156 354
193 802
156 354
163 438
Net Interest-bearing debt
2 286 255
1 358 100
2 286 255
1 358 100
1 757 437
Equity ratio (%)
46 %
54 %
46 %
54 %
49 %
Profitability
Q3 2026
Q3 2025
YTD 2026
YTD 2025
2025
Earnings per share (NOK)
-0,05
-0,10
-0,21
-0,37
-0,37
1 Calculated on a back to farm basis and adjusted for transport cost to Norway border (Sisalmoni equivalent)
2 Before fair value adjustment related to biological assets